139 related articles for article (PubMed ID: 38451242)
1. Circulating cell-free DNA-based biomarkers for prognostication and disease monitoring in adrenocortical carcinoma.
Lippert J; Smith G; Appenzeller S; Landwehr LS; Prete A; Steinhauer S; Asia M; Urlaub H; Elhassan YS; Kircher S; Arlt W; Fassnacht M; Altieri B; Ronchi CL
Eur J Endocrinol; 2024 Mar; 190(3):234-247. PubMed ID: 38451242
[TBL] [Abstract][Full Text] [Related]
2. Performance of DNA-based biomarkers for classification of adrenocortical carcinoma: a prognostic study.
Lippert J; Dischinger U; Appenzeller S; Prete A; Kircher S; Skordilis K; Elhassan YS; Altieri B; Fassnacht M; Ronchi CL
Eur J Endocrinol; 2023 Aug; 189(2):262-270. PubMed ID: 37590967
[TBL] [Abstract][Full Text] [Related]
3. Targeted Molecular Analysis in Adrenocortical Carcinomas: A Strategy Toward Improved Personalized Prognostication.
Lippert J; Appenzeller S; Liang R; Sbiera S; Kircher S; Altieri B; Nanda I; Weigand I; Gehrig A; Steinhauer S; Riemens RJM; Rosenwald A; Müller CR; Kroiss M; Rost S; Fassnacht M; Ronchi CL
J Clin Endocrinol Metab; 2018 Dec; 103(12):4511-4523. PubMed ID: 30113656
[TBL] [Abstract][Full Text] [Related]
4. Circulating Fascin 1 as a Promising Prognostic Marker in Adrenocortical Cancer.
Cantini G; Fei L; Canu L; De Filpo G; Ercolino T; Nesi G; Mannelli M; Luconi M
Front Endocrinol (Lausanne); 2021; 12():698862. PubMed ID: 34248854
[TBL] [Abstract][Full Text] [Related]
5. Circulating cell-free DNA mutation patterns in early and late stage colon and pancreatic cancer.
Vietsch EE; Graham GT; McCutcheon JN; Javaid A; Giaccone G; Marshall JL; Wellstein A
Cancer Genet; 2017 Dec; 218-219():39-50. PubMed ID: 29153095
[TBL] [Abstract][Full Text] [Related]
6. Blood-Based Next-Generation Sequencing in Adrenocortical Carcinoma.
Nazha B; Zhuang TZ; Dada HI; Drusbosky LM; Brown JT; Ravindranathan D; Carthon BC; Kucuk O; Goldman J; Master VA; Bilen MA
Oncologist; 2022 Jun; 27(6):462-468. PubMed ID: 35462410
[TBL] [Abstract][Full Text] [Related]
7. Sarcomatoid adrenocortical carcinoma: a comprehensive pathological, immunohistochemical, and targeted next-generation sequencing analysis.
Papathomas TG; Duregon E; Korpershoek E; Restuccia DF; van Marion R; Cappellesso R; Sturm N; Rossi G; Coli A; Zucchini N; Stoop H; Oosterhuis W; Ventura L; Volante M; Fassina A; Dinjens WN; Papotti M; de Krijger RR
Hum Pathol; 2016 Dec; 58():113-122. PubMed ID: 27589897
[TBL] [Abstract][Full Text] [Related]
8. Bioinformatic analyses and experimental validation of the role of m6A RNA methylation regulators in progression and prognosis of adrenocortical carcinoma.
Xu F; Guan Y; Ma Y; Xue L; Zhang P; Yang X; Chong T
Aging (Albany NY); 2021 Apr; 13(8):11919-11941. PubMed ID: 33952721
[TBL] [Abstract][Full Text] [Related]
9. Less common genotype variants of TP53 polymorphisms are associated with poor outcome in adult patients with adrenocortical carcinoma.
Heinze B; Herrmann LJ; Fassnacht M; Ronchi CL; Willenberg HS; Quinkler M; Reisch N; Zink M; Allolio B; Hahner S
Eur J Endocrinol; 2014 May; 170(5):707-17. PubMed ID: 24566897
[TBL] [Abstract][Full Text] [Related]
10. Urine Steroid Metabolomics as a Novel Tool for Detection of Recurrent Adrenocortical Carcinoma.
Chortis V; Bancos I; Nijman T; Gilligan LC; Taylor AE; Ronchi CL; O'Reilly MW; Schreiner J; Asia M; Riester A; Perotti P; Libé R; Quinkler M; Canu L; Paiva I; Bugalho MJ; Kastelan D; Dennedy MC; Sherlock M; Ambroziak U; Vassiliadi D; Bertherat J; Beuschlein F; Fassnacht M; Deeks JJ; Biehl M; Arlt W
J Clin Endocrinol Metab; 2020 Mar; 105(3):e307-18. PubMed ID: 31665449
[TBL] [Abstract][Full Text] [Related]
11. Identification of intratumor bacteria-associated prognostic risk score in adrenocortical carcinoma.
Tan L; Zhang D; Li Y-x; Li Y; Guo T; Sun Y; Li N; Feng C
Microbiol Spectr; 2024 Apr; 12(4):e0372723. PubMed ID: 38421176
[TBL] [Abstract][Full Text] [Related]
12. Targeted Assessment of
Mohan DR; Lerario AM; Else T; Mukherjee B; Almeida MQ; Vinco M; Rege J; Mariani BMP; Zerbini MCN; Mendonca BB; Latronico AC; Marie SKN; Rainey WE; Giordano TJ; Fragoso MCBV; Hammer GD
Clin Cancer Res; 2019 Jun; 25(11):3276-3288. PubMed ID: 30770352
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological and Prognostic Characteristics of CD276 (B7-H3) Expression in Adrenocortical Carcinoma.
Liang J; Liu Z; Pei T; Xiao Y; Zhou L; Tang Y; Zhou C; Wu K; Zhang F; Zhang F; Yin X; Chen N; Wei X; Lu Y; Zhu Y
Dis Markers; 2020; 2020():5354825. PubMed ID: 31998416
[TBL] [Abstract][Full Text] [Related]
14. Development and Validation of an m6A RNA Methylation Regulators-Based Signature for Predicting the Prognosis of Adrenocortical Carcinoma.
Shen C; Liu J; Yang X; Jiao W; Wang Y
Front Endocrinol (Lausanne); 2021; 12():568397. PubMed ID: 33692753
[TBL] [Abstract][Full Text] [Related]
15. Serum inhibin pro-αC is a tumor marker for adrenocortical carcinomas.
Hofland J; Feelders RA; van der Wal R; Kerstens MN; Haak HR; de Herder WW; de Jong FH
Eur J Endocrinol; 2012 Feb; 166(2):281-9. PubMed ID: 22127493
[TBL] [Abstract][Full Text] [Related]
16. Circulating Cell-Free SEPT9 DNA Methylation in Blood Is a Biomarker for Minimal Residual Disease Detection in Head and Neck Squamous Cell Carcinoma Patients.
Dietrich D; Weider S; de Vos L; Vogt TJ; Färber M; Zarbl R; Hunecke A; Glosch AK; Gabrielpillai J; Bootz F; Bauernfeind FG; Kramer FJ; Kristiansen G; Brossart P; Strieth S; Franzen A
Clin Chem; 2023 Sep; 69(9):1050-1061. PubMed ID: 37477541
[TBL] [Abstract][Full Text] [Related]
17. A New Horizon of Liquid Biopsy in Thymic Epithelial Tumors: The Potential Utility of Circulating Cell-Free DNA.
Ottaviano M; Giuliano M; Tortora M; La Civita E; Liotti A; Longo M; Bruzzese D; Cennamo M; Riccio V; De Placido P; Picozzi F; Parola S; Daniele B; Botti G; Formisano P; Beguinot F; De Placido S; Terracciano D; Palmieri G
Front Oncol; 2020; 10():602153. PubMed ID: 33634024
[TBL] [Abstract][Full Text] [Related]
18. Next-generation sequencing of adrenocortical carcinoma reveals new routes to targeted therapies.
Ross JS; Wang K; Rand JV; Gay L; Presta MJ; Sheehan CE; Ali SM; Elvin JA; Labrecque E; Hiemstra C; Buell J; Otto GA; Yelensky R; Lipson D; Morosini D; Chmielecki J; Miller VA; Stephens PJ
J Clin Pathol; 2014 Nov; 67(11):968-73. PubMed ID: 25078331
[TBL] [Abstract][Full Text] [Related]
19. Stathmin 1 is highly expressed and associated with survival outcome in malignant adrenocortical tumours.
Dos Santos Passaia B; Lima K; Kremer JL; da Conceição BB; de Paula Mariani BM; da Silva JCL; Zerbini MCN; Fragoso MCBV; Machado-Neto JA; Lotfi CFP
Invest New Drugs; 2020 Jun; 38(3):899-908. PubMed ID: 31441020
[TBL] [Abstract][Full Text] [Related]
20. Genomic stratification and liquid biopsy in a rare adrenocortical carcinoma (ACC) case, with dual lung metastases.
McCabe MJ; Pinese M; Chan CL; Sheriff N; Thompson TJ; Grady J; Wong M; Gauthier MA; Puttick C; Gayevskiy V; Hajdu E; Wong SQ; Barrett W; Earls P; Lukeis R; Cheng YY; Lin RCY; Thomas DM; Watkins DN; Dinger ME; McCormack AI; Cowley MJ
Cold Spring Harb Mol Case Stud; 2019 Apr; 5(2):. PubMed ID: 30936196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]